Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medulloblastoma | 38 | 2022 | 702 | 3.840 |
Why?
|
Cerebellar Neoplasms | 27 | 2022 | 588 | 2.650 |
Why?
|
Karyotyping | 5 | 2022 | 1253 | 1.390 |
Why?
|
DNA Copy Number Variations | 7 | 2022 | 1942 | 0.780 |
Why?
|
Hedgehog Proteins | 12 | 2014 | 777 | 0.760 |
Why?
|
Brain Neoplasms | 16 | 2022 | 8644 | 0.740 |
Why?
|
In Situ Hybridization, Fluorescence | 7 | 2022 | 2651 | 0.730 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2021 | 1559 | 0.700 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2021 | 215 | 0.690 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 606 | 0.610 |
Why?
|
Ependymoma | 3 | 2019 | 325 | 0.570 |
Why?
|
Pinealoma | 3 | 2020 | 56 | 0.470 |
Why?
|
Cytogenetic Analysis | 3 | 2022 | 302 | 0.360 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2013 | 1115 | 0.350 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2012 | 672 | 0.340 |
Why?
|
Lysine | 2 | 2012 | 1004 | 0.340 |
Why?
|
Cytogenetics | 5 | 2022 | 211 | 0.300 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2022 | 3635 | 0.300 |
Why?
|
Alternative Splicing | 1 | 2012 | 1116 | 0.290 |
Why?
|
Glioblastoma | 4 | 2023 | 3339 | 0.280 |
Why?
|
Epigenesis, Genetic | 5 | 2014 | 3596 | 0.280 |
Why?
|
Neoplasms | 7 | 2022 | 20947 | 0.280 |
Why?
|
Neoplasm Metastasis | 8 | 2020 | 4887 | 0.270 |
Why?
|
Proto-Oncogene Proteins | 5 | 2019 | 4561 | 0.270 |
Why?
|
Pleural Neoplasms | 2 | 2021 | 604 | 0.260 |
Why?
|
Chromosome Aberrations | 5 | 2022 | 1813 | 0.260 |
Why?
|
Cerebellum | 6 | 2013 | 1494 | 0.250 |
Why?
|
Ether-A-Go-Go Potassium Channels | 2 | 2015 | 76 | 0.250 |
Why?
|
Genome, Human | 7 | 2022 | 4425 | 0.230 |
Why?
|
Genomics | 10 | 2022 | 5562 | 0.230 |
Why?
|
Homeodomain Proteins | 3 | 2018 | 2424 | 0.220 |
Why?
|
Genetic Testing | 5 | 2022 | 3422 | 0.220 |
Why?
|
DNA-Binding Proteins | 5 | 2020 | 9714 | 0.210 |
Why?
|
Gene Expression Profiling | 11 | 2021 | 9375 | 0.210 |
Why?
|
MicroRNAs | 6 | 2015 | 3709 | 0.210 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 2021 | 27 | 0.200 |
Why?
|
Sex Chromosome Disorders of Sex Development | 1 | 2020 | 5 | 0.200 |
Why?
|
Genetic Variation | 3 | 2022 | 6529 | 0.190 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2021 | 719 | 0.190 |
Why?
|
Wnt Proteins | 3 | 2014 | 722 | 0.190 |
Why?
|
Signal Transduction | 12 | 2017 | 23445 | 0.190 |
Why?
|
Oncogene Proteins, Fusion | 5 | 2020 | 1589 | 0.180 |
Why?
|
Meningeal Neoplasms | 2 | 2022 | 1208 | 0.180 |
Why?
|
Solitary Fibrous Tumor, Pleural | 1 | 2019 | 27 | 0.180 |
Why?
|
Philadelphia Chromosome | 1 | 2020 | 114 | 0.180 |
Why?
|
Pineal Gland | 2 | 2017 | 163 | 0.180 |
Why?
|
Adenoma, Pleomorphic | 1 | 2020 | 77 | 0.180 |
Why?
|
Microarray Analysis | 4 | 2019 | 768 | 0.170 |
Why?
|
Genes, Tumor Suppressor | 3 | 2013 | 1092 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2022 | 1004 | 0.170 |
Why?
|
Sweat Gland Neoplasms | 1 | 2020 | 106 | 0.170 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2019 | 2973 | 0.170 |
Why?
|
E1A-Associated p300 Protein | 1 | 2019 | 132 | 0.170 |
Why?
|
Supratentorial Neoplasms | 1 | 2019 | 162 | 0.160 |
Why?
|
Transcription Factor RelA | 1 | 2019 | 285 | 0.160 |
Why?
|
Aneuploidy | 1 | 2021 | 527 | 0.160 |
Why?
|
Humans | 70 | 2022 | 725001 | 0.160 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2019 | 138 | 0.160 |
Why?
|
Lipoma | 1 | 2020 | 332 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2020 | 370 | 0.160 |
Why?
|
Infratentorial Neoplasms | 1 | 2018 | 97 | 0.160 |
Why?
|
Liposarcoma | 1 | 2020 | 323 | 0.150 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 255 | 0.150 |
Why?
|
Lung Neoplasms | 1 | 2021 | 12874 | 0.150 |
Why?
|
Infertility, Male | 1 | 2020 | 405 | 0.150 |
Why?
|
CpG Islands | 4 | 2014 | 1202 | 0.150 |
Why?
|
Loss of Heterozygosity | 1 | 2019 | 678 | 0.150 |
Why?
|
Genome | 3 | 2021 | 1800 | 0.150 |
Why?
|
Frizzled Receptors | 1 | 2016 | 84 | 0.140 |
Why?
|
Glioma | 2 | 2023 | 3312 | 0.140 |
Why?
|
Gene Fusion | 1 | 2019 | 374 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2022 | 8896 | 0.140 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2016 | 46 | 0.140 |
Why?
|
Mitogens | 1 | 2016 | 234 | 0.140 |
Why?
|
In Situ Hybridization | 1 | 2020 | 1962 | 0.140 |
Why?
|
Thioridazine | 1 | 2015 | 34 | 0.140 |
Why?
|
Genetic Markers | 2 | 2020 | 2650 | 0.140 |
Why?
|
Gene Rearrangement | 1 | 2021 | 1194 | 0.140 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2016 | 2430 | 0.140 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2019 | 320 | 0.140 |
Why?
|
Retinoblastoma | 1 | 2018 | 308 | 0.140 |
Why?
|
Cell Proliferation | 14 | 2017 | 10472 | 0.130 |
Why?
|
Repressor Proteins | 3 | 2019 | 3045 | 0.130 |
Why?
|
Kv1.1 Potassium Channel | 2 | 2012 | 33 | 0.130 |
Why?
|
Laboratories | 1 | 2019 | 455 | 0.130 |
Why?
|
Carcinoma, Large Cell | 1 | 2015 | 115 | 0.130 |
Why?
|
Transcription Factors | 5 | 2022 | 12081 | 0.130 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 632 | 0.130 |
Why?
|
Lysosomes | 1 | 2020 | 906 | 0.130 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2016 | 725 | 0.130 |
Why?
|
Mutation | 12 | 2019 | 29645 | 0.130 |
Why?
|
Cluster Analysis | 4 | 2020 | 2762 | 0.130 |
Why?
|
Nuclear Proteins | 4 | 2014 | 5915 | 0.120 |
Why?
|
Nerve Tissue Proteins | 4 | 2016 | 4497 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 4 | 2019 | 17328 | 0.120 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1241 | 0.120 |
Why?
|
DNA Mutational Analysis | 5 | 2016 | 4249 | 0.120 |
Why?
|
Germ-Line Mutation | 2 | 2020 | 1796 | 0.120 |
Why?
|
Elongation Factor 2 Kinase | 1 | 2013 | 11 | 0.120 |
Why?
|
Mice | 23 | 2023 | 80318 | 0.120 |
Why?
|
Forkhead Transcription Factors | 2 | 2019 | 1614 | 0.120 |
Why?
|
DNA Methylation | 6 | 2014 | 4314 | 0.120 |
Why?
|
Meningioma | 1 | 2022 | 1175 | 0.120 |
Why?
|
Peptide Chain Elongation, Translational | 1 | 2013 | 35 | 0.120 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 472 | 0.120 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 689 | 0.120 |
Why?
|
Gene Transfer Techniques | 2 | 2015 | 1244 | 0.110 |
Why?
|
MyoD Protein | 1 | 2013 | 159 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2015 | 8453 | 0.110 |
Why?
|
Eye Proteins | 1 | 2016 | 650 | 0.110 |
Why?
|
Clone Cells | 1 | 2016 | 1697 | 0.110 |
Why?
|
NF-kappa B | 2 | 2019 | 2549 | 0.110 |
Why?
|
Gene Deletion | 5 | 2021 | 2800 | 0.110 |
Why?
|
Genomic Structural Variation | 1 | 2012 | 65 | 0.110 |
Why?
|
Receptors, Atrial Natriuretic Factor | 1 | 2012 | 55 | 0.110 |
Why?
|
Pyrazoles | 3 | 2020 | 1926 | 0.110 |
Why?
|
Mutagenesis, Insertional | 4 | 2019 | 656 | 0.100 |
Why?
|
Anilides | 1 | 2014 | 411 | 0.100 |
Why?
|
Mice, Nude | 5 | 2019 | 3716 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 1 | 2021 | 1356 | 0.100 |
Why?
|
Cell Cycle Proteins | 2 | 2014 | 3466 | 0.100 |
Why?
|
Mice, Transgenic | 8 | 2015 | 9792 | 0.100 |
Why?
|
Sequence Analysis, DNA | 3 | 2017 | 4865 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1486 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1726 | 0.100 |
Why?
|
Comparative Genomic Hybridization | 3 | 2017 | 501 | 0.100 |
Why?
|
Neuroblastoma | 1 | 2018 | 1183 | 0.100 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 383 | 0.100 |
Why?
|
Pyrimidines | 3 | 2020 | 2895 | 0.090 |
Why?
|
Cell Size | 1 | 2012 | 645 | 0.090 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2012 | 342 | 0.090 |
Why?
|
Oncogene Fusion | 2 | 2021 | 104 | 0.090 |
Why?
|
Histone Demethylases | 1 | 2012 | 316 | 0.090 |
Why?
|
Epigenomics | 2 | 2014 | 855 | 0.090 |
Why?
|
Methylation | 1 | 2012 | 1112 | 0.090 |
Why?
|
Quinolines | 1 | 2014 | 723 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2012 | 3708 | 0.090 |
Why?
|
Histones | 4 | 2014 | 2561 | 0.090 |
Why?
|
Radiation Tolerance | 1 | 2012 | 488 | 0.090 |
Why?
|
Gene Regulatory Networks | 3 | 2012 | 1718 | 0.090 |
Why?
|
Male | 32 | 2021 | 346964 | 0.090 |
Why?
|
Animals | 25 | 2023 | 168735 | 0.090 |
Why?
|
Prenatal Diagnosis | 1 | 2016 | 1199 | 0.090 |
Why?
|
Freezing | 1 | 2009 | 304 | 0.090 |
Why?
|
Female | 29 | 2021 | 375303 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1391 | 0.080 |
Why?
|
Cell Line, Tumor | 9 | 2015 | 16634 | 0.080 |
Why?
|
Adult | 19 | 2022 | 211523 | 0.080 |
Why?
|
Neoplasms, Second Primary | 1 | 2016 | 1023 | 0.080 |
Why?
|
Blotting, Western | 5 | 2017 | 5237 | 0.080 |
Why?
|
Telomerase | 1 | 2013 | 733 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2020 | 2935 | 0.080 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2014 | 838 | 0.080 |
Why?
|
Hibernation | 1 | 2008 | 49 | 0.080 |
Why?
|
Sciuridae | 1 | 2008 | 79 | 0.080 |
Why?
|
Prognosis | 10 | 2022 | 28718 | 0.080 |
Why?
|
Fetus | 2 | 2013 | 1847 | 0.080 |
Why?
|
Disease Models, Animal | 6 | 2020 | 18040 | 0.080 |
Why?
|
Child | 15 | 2019 | 75163 | 0.080 |
Why?
|
Transforming Growth Factor beta | 2 | 2012 | 1996 | 0.080 |
Why?
|
Trans-Activators | 1 | 2017 | 2982 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1711 | 0.080 |
Why?
|
Software | 1 | 2021 | 4404 | 0.080 |
Why?
|
DNA Transposable Elements | 3 | 2019 | 743 | 0.070 |
Why?
|
Cell Adhesion | 1 | 2014 | 3178 | 0.070 |
Why?
|
Mitosis | 1 | 2012 | 1246 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2015 | 3965 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 11952 | 0.070 |
Why?
|
Receptors, CXCR4 | 1 | 2011 | 729 | 0.070 |
Why?
|
Aged | 10 | 2021 | 161379 | 0.070 |
Why?
|
Evolution, Molecular | 1 | 2015 | 1940 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2227 | 0.070 |
Why?
|
Cadherins | 1 | 2011 | 911 | 0.070 |
Why?
|
Proteins | 2 | 2019 | 6084 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2015 | 3575 | 0.070 |
Why?
|
Genetics, Medical | 2 | 2019 | 339 | 0.070 |
Why?
|
Computational Biology | 3 | 2015 | 3522 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2149 | 0.070 |
Why?
|
Gene Silencing | 4 | 2014 | 1568 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2015 | 2759 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2013 | 5934 | 0.070 |
Why?
|
Young Adult | 8 | 2021 | 55791 | 0.060 |
Why?
|
Cell Movement | 5 | 2015 | 5284 | 0.060 |
Why?
|
Base Sequence | 2 | 2012 | 12981 | 0.060 |
Why?
|
Caenorhabditis elegans | 1 | 2013 | 1426 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2012 | 1379 | 0.060 |
Why?
|
RNA Interference | 2 | 2015 | 2957 | 0.060 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2015 | 188 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2015 | 2227 | 0.060 |
Why?
|
Neural Stem Cells | 3 | 2019 | 850 | 0.060 |
Why?
|
Child, Preschool | 9 | 2018 | 40429 | 0.060 |
Why?
|
Chromosome Deletion | 2 | 2020 | 1394 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2012 | 1905 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 3400 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3525 | 0.060 |
Why?
|
Cohort Studies | 5 | 2022 | 39883 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2015 | 6370 | 0.050 |
Why?
|
SOX9 Transcription Factor | 1 | 2022 | 147 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2021 | 57615 | 0.050 |
Why?
|
Gene Dosage | 2 | 2017 | 1266 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2019 | 7914 | 0.050 |
Why?
|
COS Cells | 2 | 2015 | 1188 | 0.050 |
Why?
|
Middle Aged | 11 | 2021 | 212155 | 0.050 |
Why?
|
Mice, Inbred BALB C | 3 | 2015 | 6440 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5169 | 0.050 |
Why?
|
Gene Amplification | 2 | 2020 | 1073 | 0.050 |
Why?
|
Adolescent | 10 | 2021 | 84411 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2012 | 13045 | 0.050 |
Why?
|
Apoptosis | 5 | 2016 | 9754 | 0.050 |
Why?
|
Sex Chromosome Aberrations | 1 | 2020 | 110 | 0.050 |
Why?
|
Cell Cycle | 3 | 2014 | 2980 | 0.050 |
Why?
|
Nortriptyline | 1 | 2020 | 79 | 0.050 |
Why?
|
Translocation, Genetic | 2 | 2018 | 1419 | 0.050 |
Why?
|
Piperidines | 2 | 2019 | 1565 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2014 | 19620 | 0.050 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2019 | 41 | 0.050 |
Why?
|
Genes, p53 | 2 | 2012 | 763 | 0.040 |
Why?
|
Chromosomes, Human, Y | 1 | 2020 | 147 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2017 | 15404 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 2 | 2015 | 1147 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4799 | 0.040 |
Why?
|
Infant | 6 | 2018 | 34331 | 0.040 |
Why?
|
Mice, SCID | 2 | 2014 | 2727 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 10879 | 0.040 |
Why?
|
Neurofibromin 2 | 1 | 2019 | 272 | 0.040 |
Why?
|
Calcitonin | 1 | 2019 | 337 | 0.040 |
Why?
|
Carbazoles | 1 | 2019 | 232 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1316 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11486 | 0.040 |
Why?
|
Integrases | 1 | 2020 | 539 | 0.040 |
Why?
|
Phenotype | 4 | 2019 | 16262 | 0.040 |
Why?
|
Mosaicism | 1 | 2020 | 442 | 0.040 |
Why?
|
Ribonuclease III | 2 | 2009 | 282 | 0.040 |
Why?
|
RNA | 2 | 2020 | 2708 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 442 | 0.040 |
Why?
|
Retinoblastoma Protein | 1 | 2020 | 702 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6527 | 0.040 |
Why?
|
Chromosome Banding | 1 | 2016 | 279 | 0.040 |
Why?
|
World Health Organization | 1 | 2022 | 1302 | 0.040 |
Why?
|
Histiocytic Sarcoma | 1 | 2016 | 45 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2015 | 3601 | 0.030 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 486 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2017 | 466 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2015 | 22139 | 0.030 |
Why?
|
Cell Transdifferentiation | 1 | 2016 | 172 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2014 | 2382 | 0.030 |
Why?
|
Transfection | 2 | 2015 | 5963 | 0.030 |
Why?
|
Documentation | 1 | 2021 | 855 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 12183 | 0.030 |
Why?
|
Chromosomes | 1 | 2018 | 610 | 0.030 |
Why?
|
Pediatrics | 1 | 2010 | 3441 | 0.030 |
Why?
|
Guanine Nucleotide Dissociation Inhibitors | 1 | 2014 | 27 | 0.030 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2018 | 341 | 0.030 |
Why?
|
Tumor Stem Cell Assay | 1 | 2014 | 119 | 0.030 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2014 | 40 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 609 | 0.030 |
Why?
|
Rhombencephalon | 1 | 2014 | 84 | 0.030 |
Why?
|
Peptide Elongation Factor 2 | 1 | 2013 | 17 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12937 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2019 | 1384 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2014 | 304 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2015 | 358 | 0.030 |
Why?
|
Food Deprivation | 1 | 2013 | 122 | 0.030 |
Why?
|
Protein Biosynthesis | 2 | 2012 | 2141 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2017 | 11511 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5458 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2012 | 4221 | 0.030 |
Why?
|
Cathepsin B | 1 | 2012 | 84 | 0.030 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2014 | 417 | 0.030 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2012 | 85 | 0.030 |
Why?
|
Cell Survival | 2 | 2013 | 5908 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2015 | 399 | 0.030 |
Why?
|
Genetic Counseling | 1 | 2016 | 587 | 0.030 |
Why?
|
Smad3 Protein | 1 | 2012 | 182 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2012 | 356 | 0.030 |
Why?
|
Chromatography, Thin Layer | 1 | 2012 | 232 | 0.030 |
Why?
|
Pteridines | 1 | 2012 | 47 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2014 | 559 | 0.030 |
Why?
|
Autophagy | 1 | 2020 | 1301 | 0.030 |
Why?
|
Electrophoresis, Capillary | 1 | 2012 | 68 | 0.030 |
Why?
|
DNA Restriction Enzymes | 1 | 2012 | 603 | 0.030 |
Why?
|
Sulfites | 1 | 2012 | 90 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2014 | 371 | 0.030 |
Why?
|
Intermediate Filament Proteins | 1 | 2012 | 275 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2013 | 682 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2014 | 824 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2016 | 902 | 0.020 |
Why?
|
Abortion, Spontaneous | 1 | 2016 | 509 | 0.020 |
Why?
|
Gene Duplication | 1 | 2012 | 330 | 0.020 |
Why?
|
Adenine | 1 | 2016 | 909 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2023 | 74145 | 0.020 |
Why?
|
Genes, myc | 1 | 2012 | 403 | 0.020 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2012 | 118 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2014 | 510 | 0.020 |
Why?
|
Meninges | 1 | 2012 | 188 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2012 | 510 | 0.020 |
Why?
|
Cytosine | 1 | 2012 | 223 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2014 | 588 | 0.020 |
Why?
|
Spheroids, Cellular | 1 | 2012 | 341 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 734 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2013 | 940 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2012 | 325 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 922 | 0.020 |
Why?
|
Ranidae | 1 | 2009 | 35 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 615 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1782 | 0.020 |
Why?
|
Genotype | 2 | 2015 | 12882 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4349 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2015 | 872 | 0.020 |
Why?
|
Cell Death | 1 | 2015 | 1705 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1872 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2094 | 0.020 |
Why?
|
Carrier Proteins | 2 | 2012 | 5041 | 0.020 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2012 | 668 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2691 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2015 | 14770 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2881 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2014 | 985 | 0.020 |
Why?
|
Canada | 1 | 2013 | 1987 | 0.020 |
Why?
|
Proteoglycans | 1 | 2011 | 839 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2017 | 3008 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2014 | 2747 | 0.020 |
Why?
|
Drosophila | 1 | 2015 | 1492 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2571 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2014 | 1615 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1668 | 0.020 |
Why?
|
Adenosine | 1 | 2012 | 804 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2014 | 19487 | 0.020 |
Why?
|
Europe | 1 | 2013 | 3293 | 0.020 |
Why?
|
Remission Induction | 1 | 2012 | 2366 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3449 | 0.020 |
Why?
|
HeLa Cells | 1 | 2013 | 3163 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6725 | 0.020 |
Why?
|
Disease Progression | 2 | 2013 | 13161 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 1328 | 0.020 |
Why?
|
Chromatin | 1 | 2017 | 2852 | 0.020 |
Why?
|
Probability | 1 | 2011 | 2485 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2012 | 3739 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2012 | 1536 | 0.020 |
Why?
|
Age of Onset | 1 | 2011 | 3259 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2009 | 1547 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13563 | 0.020 |
Why?
|
Models, Neurological | 1 | 2012 | 1772 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2008 | 2360 | 0.020 |
Why?
|
Spinal Cord | 1 | 2012 | 1810 | 0.020 |
Why?
|
Down-Regulation | 1 | 2011 | 3026 | 0.010 |
Why?
|
Cell Lineage | 1 | 2012 | 2519 | 0.010 |
Why?
|
Muscle, Skeletal | 2 | 2009 | 4956 | 0.010 |
Why?
|
Organ Specificity | 1 | 2008 | 2022 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8577 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4234 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2012 | 2877 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10968 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6434 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5970 | 0.010 |
Why?
|
Phosphorylation | 1 | 2012 | 8492 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3821 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 2005 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10244 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 18297 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12318 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 14955 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 16263 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12795 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 70971 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13356 | 0.010 |
Why?
|
Myocardium | 1 | 2008 | 4811 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2012 | 21575 | 0.010 |
Why?
|
Liver | 1 | 2009 | 7505 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 61674 | 0.010 |
Why?
|
Neurons | 1 | 2012 | 9342 | 0.010 |
Why?
|
Kidney | 1 | 2008 | 7022 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23178 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 40178 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 51853 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 34755 | 0.010 |
Why?
|
United States | 1 | 2013 | 68433 | 0.000 |
Why?
|